Literature DB >> 17804649

Clinical features and complete genome characterization of a distinct human rhinovirus (HRV) genetic cluster, probably representing a previously undetected HRV species, HRV-C, associated with acute respiratory illness in children.

Susanna K P Lau1, Cyril C Y Yip, Hoi-Wah Tsoi, Rodney A Lee, Lok-Yee So, Yu-Lung Lau, Kwok-Hung Chan, Patrick C Y Woo, Kwok-Yung Yuen.   

Abstract

Although human rhinoviruses (HRVs) are common causes of respiratory illness, their molecular epidemiology has been poorly investigated. Despite the recent findings of new HRV genotypes, their clinical disease spectrum and phylogenetic positions were not fully understood. In this study, 203 prospectively collected nasopharyngeal aspirates (NPAs), negative for common respiratory viruses (83 were human bocavirus [HBoV] positive and 120 HBoV negative), from hospitalized children during a 1-year period were subjected to reverse transcription-PCR for HRV. HRV was detected in 14 NPAs positive and 12 NPAs negative for HBoV. Upon VP4 gene analysis, 5 of these 26 HRV strains were found to belong to HRV-A while 21 belonged to a genetic clade probably representing a previously undetected HRV species, HRV-C, that is phylogenetically distinct from the two known HRV species, HRV-A and HRV-B. The VP4 sequences of these HRV-C strains were closely related to the newly identified HRV strains from the United States and Australia. Febrile wheeze or asthma was the most common presentation (76%) of HRV-C infection, which peaked in fall and winter. Complete genome sequencing of three HRV-C strains revealed that HRV-C represents an additional HRV species, with features distinct from HRV-A and HRV-B. Analysis of VP1 of HRV-C revealed major deletions in regions important for neutralization in other HRVs, which may be signs of a distinct species, while within-clade amino acid variation in potentially antigenic regions may indicate the existence of different serotypes among HRV-C strains. A newly identified HRV species, HRV-C, is circulating worldwide and is an important cause of febrile wheeze and asthmatic exacerbations in children requiring hospitalization.

Entities:  

Mesh:

Year:  2007        PMID: 17804649      PMCID: PMC2168475          DOI: 10.1128/JCM.01254-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  42 in total

1.  Evolutionary relationships within the human rhinovirus genus: comparison of serotypes 89, 2, and 14.

Authors:  M Duechler; T Skern; W Sommergruber; C Neubauer; P Gruendler; I Fogy; D Blaas; E Kuechler
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

2.  The nucleotide sequence of human rhinovirus 1B: molecular relationships within the rhinovirus genus.

Authors:  P J Hughes; C North; C H Jellis; P D Minor; G Stanway
Journal:  J Gen Virol       Date:  1988-01       Impact factor: 3.891

3.  Molecular cloning and complete sequence determination of RNA genome of human rhinovirus type 14.

Authors:  P L Callahan; S Mizutani; R J Colonno
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

4.  Evidence for at least two dominant neutralization antigens on human rhinovirus 14.

Authors:  B Sherry; R Rueckert
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

5.  Structure of a human common cold virus and functional relationship to other picornaviruses.

Authors:  M G Rossmann; E Arnold; J W Erickson; E A Frankenberger; J P Griffith; H J Hecht; J E Johnson; G Kamer; M Luo; A G Mosser
Journal:  Nature       Date:  1985 Sep 12-18       Impact factor: 49.962

6.  The complete nucleotide sequence of a common cold virus: human rhinovirus 14.

Authors:  G Stanway; P J Hughes; R C Mountford; P D Minor; J W Almond
Journal:  Nucleic Acids Res       Date:  1984-10-25       Impact factor: 16.971

7.  Human rhinovirus 2: complete nucleotide sequence and proteolytic processing signals in the capsid protein region.

Authors:  T Skern; W Sommergruber; D Blaas; P Gruendler; F Fraundorfer; C Pieler; I Fogy; E Kuechler
Journal:  Nucleic Acids Res       Date:  1985-03-25       Impact factor: 16.971

8.  The major and minor group receptor families contain all but one human rhinovirus serotype.

Authors:  C R Uncapher; C M DeWitt; R J Colonno
Journal:  Virology       Date:  1991-02       Impact factor: 3.616

9.  A previously undescribed coronavirus associated with respiratory disease in humans.

Authors:  Ron A M Fouchier; Nico G Hartwig; Theo M Bestebroer; Berend Niemeyer; Jan C de Jong; James H Simon; Albert D M E Osterhaus
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-08       Impact factor: 11.205

10.  Identification of a new human coronavirus.

Authors:  Lia van der Hoek; Krzysztof Pyrc; Maarten F Jebbink; Wilma Vermeulen-Oost; Ron J M Berkhout; Katja C Wolthers; Pauline M E Wertheim-van Dillen; Jos Kaandorp; Joke Spaargaren; Ben Berkhout
Journal:  Nat Med       Date:  2004-03-21       Impact factor: 53.440

View more
  173 in total

1.  Complete genome sequence of a novel picornavirus, canine picornavirus, discovered in dogs.

Authors:  Patrick C Y Woo; Susanna K P Lau; Garnet K Y Choi; Cyril C Y Yip; Yi Huang; Hoi-Wah Tsoi; Kwok-Yung Yuen
Journal:  J Virol       Date:  2012-03       Impact factor: 5.103

2.  Development and assay of RNA transcripts of enterovirus species A to D, rhinovirus species a to C, and human parechovirus: assessment of assay sensitivity and specificity of real-time screening and typing methods.

Authors:  Nigel J McLeish; Jeroen Witteveldt; Lucy Clasper; Chloe McIntyre; E Carol McWilliam Leitch; Alison Hardie; Susan Bennett; Rory Gunson; William F Carman; Susan A Feeney; Peter V Coyle; Barry Vipond; Peter Muir; Kimberley Benschop; Katja Wolthers; Matti Waris; Riikka Osterback; Ingo Johannessen; Kate Templeton; Heli Harvala; Peter Simmonds
Journal:  J Clin Microbiol       Date:  2012-06-27       Impact factor: 5.948

Review 3.  Microbe hunting.

Authors:  W Ian Lipkin
Journal:  Microbiol Mol Biol Rev       Date:  2010-09       Impact factor: 11.056

4.  Analysis of genetic diversity and sites of recombination in human rhinovirus species C.

Authors:  Chloe L McIntyre; E Carol McWilliam Leitch; Carita Savolainen-Kopra; Tapani Hovi; Peter Simmonds
Journal:  J Virol       Date:  2010-07-28       Impact factor: 5.103

Review 5.  Clinical and molecular features of human rhinovirus C.

Authors:  Yury A Bochkov; James E Gern
Journal:  Microbes Infect       Date:  2012-01-12       Impact factor: 2.700

6.  5' noncoding region alone does not unequivocally determine genetic type of human rhinovirus strains.

Authors:  Carita Savolainen-Kopra; Soile Blomqvist; Teemu Smura; Merja Roivainen; Tapani Hovi; David Kiang; Ishmeet Kalra; Shigeo Yagi; Janice K Louie; Homer Boushey; John Boothby; David P Schnurr
Journal:  J Clin Microbiol       Date:  2009-04       Impact factor: 5.948

7.  Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type C.

Authors:  Chris Mello; Esmeralda Aguayo; Madeleine Rodriguez; Gary Lee; Robert Jordan; Tomas Cihlar; Gabriel Birkus
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

8.  Uncoating of common cold virus is preceded by RNA switching as determined by X-ray and cryo-EM analyses of the subviral A-particle.

Authors:  Angela Pickl-Herk; Daniel Luque; Laia Vives-Adrián; Jordi Querol-Audí; Damià Garriga; Benes L Trus; Nuria Verdaguer; Dieter Blaas; José R Castón
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-25       Impact factor: 11.205

Review 9.  Analysis of the complete genome sequences of human rhinovirus.

Authors:  Ann C Palmenberg; Jennifer A Rathe; Stephen B Liggett
Journal:  J Allergy Clin Immunol       Date:  2010-05-14       Impact factor: 10.793

10.  Infection and propagation of human rhinovirus C in human airway epithelial cells.

Authors:  Weidong Hao; Katie Bernard; Nita Patel; Nancy Ulbrandt; Hui Feng; Catherine Svabek; Susan Wilson; Christina Stracener; Kathy Wang; Joann Suzich; Wade Blair; Qing Zhu
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.